Key result
Combined endothelial dysfunction and insulin resistance linked to ~555% greater heart failure risk in hypertensives.
Why the study?
Although insulin resistance and endothelial dysfunction are associated with HF, whether they independently predict incident HF and interact with each other remained to be investigated.
Do insulin resistance and endothelial dysfunction predict incident heart failure in never-treated hypertensives?
Cohort (n=705)
Do insulin resistance and endothelial dysfunction predict incident heart failure in never-treated hypertensives?
Both endothelial dysfunction and insulin resistance are independent predictors of incident heart failure in hypertensive patients, with a significant competitive interaction between the two risk factors.
May inform HF risk stratification in hypertensives; hypothesis-generating for competitive interaction and needs prospective validation.
Insulin resistance and endothelial dysfunction are associated with heart failure (HF). Our objective was to investigate whether endothelial dysfunction and insulin resistance are independent predictors of incident HF and if a possible interaction exists between them. We enrolled 705 white never-treated hypertensives. Endothelium-dependent vasodilation was investigated by intra-arterial infusion of acetylcholine. During the follow-up [median: 117 months (range: 31–211)], we documented 223 new cases of HF (3.3 events/100 patient-years). We stratified the study population into progressors and non-progressors; progressors showed an older age and a higher prevalence of females, as well as higher mean values of baseline glucose, insulin, homeostasis model assessment (HOMA), creatinine, and high-sensitivity C-reactive protein (hs-CRP), whereas the estimated glomerular filtration rate (e-GFR) and endothelium-dependent vasodilation were lower. In the multiple Cox regression analysis, serum hs-CRP (HR = 1.362, (95% CI = 1.208–1.536), HOMA (HR = 1.293, 95% CI = 1.142–1.465), maximal acetylcholine (Ach)-stimulated forearm blood flow (FBF) (100% increment, HR = 0.807, 95% CI = 0.697–0.934), and e-GFR (10 mL/min/1.73 m2 increment, HR = 0.552, 95% CI = 0.483–0.603) maintained an independent association with incident HF. HOMA and endothelial dysfunction interact between them in a competitive manner (HR = 6.548, 95% CI = 4.034–10.629), also showing a mutual effect modification. Our findings demonstrate that both endothelial dysfunction and HOMA are independent and strong predictors of incident HF in hypertensives, these two risk factors interact between them with a competitive mechanism.
No takes yet. Share an insight, caveat, or question.
Perticone et al. (2023) conducted a cohort in Hypertension (n=705). Insulin resistance (HOMA) and endothelial dysfunction was evaluated on Incident heart failure (Interaction HR 6.548, 95% CI 4.034-10.629). Both endothelial dysfunction and insulin resistance independently predicted incident heart failure in hypertensives and interacted competitively (interaction HR 6.548; 95% CI 4.034-10.629).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: